Literature DB >> 21966137

Pancreaticoduodenectomy in a government medical college-should we proceed!!!

Devi Prasad Patra, Abhimanyu Basu, Susnata De, Shivam Vatsal.   

Abstract

The value of standard Pancreaticoduodenectomy for Periampullary carcinomas has long been a matter of debate. Though the mortality has dramatically reduced in high volume centers with dedicated hepatobiliary surgery units, the rate is still high in peripheral institutes. In this study our aim was to access the overall post operative outcome associated with pancreaticoduodenectomy performed in a government medical college. A total of 44 patients who underwent pancreaticoduodenectomy for operable periampullary cancers were evaluated. The overall morbidity rate was 31.1%. A total of 13 (29.5%) died following the operation and of its complications though the rate has reduced drastically to 14.2% in2008. The average length of hospital stay was 22 days. The mean survival was 15 months. Pancreaticoduodenectomy can safely be performed in government medical colleges with good results. In view of the majority of the patients in rural and suburban communities, not all patients need referral to higher centers.

Entities:  

Keywords:  Government medical colleges; Outcome; Pancreaticoduodenectomy

Year:  2010        PMID: 21966137      PMCID: PMC3077146          DOI: 10.1007/s12262-010-0153-x

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  15 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: drainage versus resection of the pancreatic remnant.

Authors:  M I van Berge Henegouwen; L T De Wit; T M Van Gulik; H Obertop; D J Gouma
Journal:  J Am Coll Surg       Date:  1997-07       Impact factor: 6.113

3.  Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Authors:  T A Sohn; C J Yeo; J L Cameron; L Koniaris; S Kaushal; R A Abrams; P K Sauter; J Coleman; R H Hruban; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.452

4.  The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma.

Authors:  G Crile
Journal:  Surg Gynecol Obstet       Date:  1970-06

5.  Risk factors of pancreatic leakage after pancreaticoduodenectomy.

Authors:  Yin-Mo Yang; Xiao-Dong Tian; Yan Zhuang; Wei-Min Wang; Yuan-Lian Wan; Yan-Ting Huang
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

6.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

7.  Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula.

Authors:  John W Lin; John L Cameron; Charles J Yeo; Taylor S Riall; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2004-12       Impact factor: 3.452

8.  Pancreas cancer resection outcome in American University centers in 1989-1990.

Authors:  S B Edge; R E Schmieg; L K Rosenlof; M C Wilhelm
Journal:  Cancer       Date:  1993-06-01       Impact factor: 6.860

9.  Periampullary adenocarcinoma: analysis of 5-year survivors.

Authors:  C J Yeo; T A Sohn; J L Cameron; R H Hruban; K D Lillemoe; H A Pitt
Journal:  Ann Surg       Date:  1998-06       Impact factor: 12.969

10.  Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management.

Authors:  J J Cullen; M G Sarr; D M Ilstrup
Journal:  Am J Surg       Date:  1994-10       Impact factor: 2.565

View more
  1 in total

1.  Outcome of Pancreaticoduodenectomy at Low-Volume Centre in Tier-II City of India.

Authors:  Kumar Vinchurkar; Vishwanath M Pattanshetti; Manoj Togale; Santosh Hazare; Varadraj Gokak
Journal:  Indian J Surg Oncol       Date:  2018-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.